- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT01915121
An Educational Intervention for Patients With Bladder Cancer
An Educational Intervention for Patients With Bladder Cancer 121193-MRSG-11-103-01-CPPB American Cancer Society
The study main objectives are to enhance treatment decision making and improve quality of life and post-treatment health care among patients diagnosed with invasive bladder cancer.
Bladder cancer (BL Ca) is the 5th most commonly diagnosed cancer in the US . BL Ca is more common among men than women and 90% of all patients are over the age of 55. Surgery to remove the bladder followed by one of three diversion techniques (i.e., ileal conduit, continent reservoir, and neobladder) is the standard therapy following invasive bladder cancer. The emotional, functional, physical, and social impact of invasive Bl Ca treatment on patients' QOL and adjustment can be devastating. This impact significantly varies by treatment option. Treatment decision making in for BL Ca is difficult at best and potentially susceptible to a number of cognitive and affective factors (e.g., patients' emotional reaction, values, and expectations). Thus, in addition to adjusting to a potential life-threatening disease, having to cope with uncertainty about the efficacy and outcomes of different treatment options adds to the overall distress and may impair effective decision-making. In spite of increasing efforts in health communication and patient education, no study has examined treatment decision making among invasive bladder patients or has provided an educational intervention to facilitate treatment decision making among this population. To this end, and guided by the Self-Regulation theory (SRT) that emphasizes the role of cognitive and emotional factors in decision making, we have designed and pilot tested the acceptability of a preliminary educational and training experiential intervention (ETE) to address this gap in the literature. The ETE intervention uses new and innovative educational strategies and methods to educate patients about their treatment options and to facilitate their treatment decision making.
Přehled studie
Postavení
Podmínky
Intervence / Léčba
Detailní popis
The goals of the study are: 1) to further enhance the design and application of the ETE intervention, and 2) to provide data on the efficacy of the refined ETE intervention in a randomized-controlled study (RCT). To achieve these 2 goals, the study is divided in to 2 phases.
PHASE 1: To enhance and refine the design and application of the preliminary ETE intervention:
Aim 1-a: To explore knowledge, beliefs, values and expectations about treatment options, treatment decision making, and quality of life (QOL) among patients with BL Ca.
To achieve Aim 1-a of Phase 1, as a first step, 2 focus groups (FG; N = 10 each) of invasive BL Ca patients will be conducted to a) examine knowledge, beliefs, values, expectations, and affective responses about treatment options and treatment decision making, b) record difficulties and problems in post-surgical health care (e.g., using stoma appliances and catheters), and c) explore concerns patients have as they live with the impact of treatment. The ETE intervention will be refined based on FG results.
Aim 1-b: To explore patients' acceptability of the refined ETE intervention. To achieve Aim 1-b of Phase 1, additional 2 FG (FG; N = 10 each) of BL Ca survivors will be conducted to solicit input about the design and acceptability of the refined ETE intervention.
PHASE 2: Aim 2. To assess the efficacy of the ETE intervention in small RCT To achieve Aim 2 of Phase 2, a two-group RCT (standard care (SC) plus time and attention control condition, N = 62 patients; SC plus ETE intervention N = 62 patients) will be conducted to examine the efficacy of the ETE intervention. Phase 2 will provide a) a test of the efficacy of the refined ETE intervention for reducing decisional conflict and regret, and improving QOL and post-treatment stoma and pouch care controlling for potential clinical and socio-demographic covariates (e.g., treatment type, age).
Typ studie
Zápis (Aktuální)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
New York
-
New York, New York, Spojené státy, 10029
- Icahn School of Medicine at Mount Sinai
-
The Bronx, New York, Spojené státy, 10468
- James J. Peters VA Medical Center
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Phase 1 (Focus groups/ In-depth Interview)
Inclusion Criteria:
- treatment of invasive Bladder Cancer a with cystectomy and one of the three major urinary diversion methods
- English speaking
- between the ages of 18 and 85
- able and willing to provide informed consent
- may have received neoadjuvant or adjuvant chemotherapy, radiation therapy, and immunotherapy (BCG)
Exclusion Criteria:
- metastatic disease or cancer recurrence
- presence of other primary cancers
- no access to a telephone
Phase 2 (randomized-controlled-study)
Additional Exclusion Criteria:
- treatment decision is made and /beginning/completion of treatment.
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Singl
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Aktivní komparátor: Education Intervention
In this session, participant will be provided with information about bladder cancer treatment options, and training tools directly related to Bladder Cancer.
|
1-hour educational and training sessions.
In this session, participant will be provided with information about bladder cancer treatment options, and training tools directly related to Bladder Cancer.
In 4 to 5 days following the session, participants will be asked to schedule the time to talk about experience and how the intervention affects their treatment decision making and to answer some questions about the educational and training session they attended.
Participants will then be called after 1-month, 3-month, and 6-month after their bladder cancer treatment to follow up.
|
|
Komparátor placeba: Nutrition Intervention
In this session, participant will be provided with information about nutrition information directly related to bladder cancer recovery
|
1-hour educational and training sessions.
In this session, participant will be provided with nutrition information directly related to Bladder Cancer recovery.
In 4 to 5 days following the session, participants will be asked to schedule the time to talk about experience and how the intervention affects their treatment decision making and to answer some questions about the educational and training session they attended.
Participants will then be called after 1-month, 3-month, and 6-month after their bladder cancer treatment to follow up.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Decisional Regret Scale
Časové okno: Baseline
|
The intervention is designed to enhance treatment decision making.
|
Baseline
|
|
Decisional Regret Scale
Časové okno: 1 month follow up
|
The intervention is designed to enhance treatment decision making.
|
1 month follow up
|
|
Decisional Regret Scale
Časové okno: 3 month follow up
|
The intervention is designed to enhance treatment decision making.
|
3 month follow up
|
|
Decisional Regret Scale
Časové okno: 6 month follow up
|
The intervention is designed to enhance treatment decision making.
|
6 month follow up
|
|
Decisional Self-Efficacy Scale
Časové okno: Baseline
|
The intervention is designed to enhance treatment decision making.
|
Baseline
|
|
Decisional Self-Efficacy Scale
Časové okno: 1 month follow up
|
The intervention is designed to enhance treatment decision making.
|
1 month follow up
|
|
Decisional Self-Efficacy Scale
Časové okno: 3 month follow up
|
The intervention is designed to enhance treatment decision making.
|
3 month follow up
|
|
Decisional Self-Efficacy Scale
Časové okno: 6 month follow up
|
The intervention is designed to enhance treatment decision making.
|
6 month follow up
|
|
Treatment-related Values
Časové okno: Baseline
|
The intervention is designed to enhance treatment decision making.
|
Baseline
|
|
Treatment-related Values
Časové okno: 1 month follow up
|
The intervention is designed to enhance treatment decision making.
|
1 month follow up
|
|
Treatment-related Values
Časové okno: 3 month follow up
|
The intervention is designed to enhance treatment decision making.
|
3 month follow up
|
|
Treatment-related Values
Časové okno: 6 month follow up
|
The intervention is designed to enhance treatment decision making.
|
6 month follow up
|
|
Decisional Regret Scale
Časové okno: Baseline
|
Bladder Cancer knowledge Scale The intervention is designed to enhance treatment decision making. |
Baseline
|
|
Decisional Regret Scale
Časové okno: 1 month follow up
|
Bladder Cancer knowledge Scale The intervention is designed to enhance treatment decision making. |
1 month follow up
|
|
Decisional Regret Scale
Časové okno: 3 month follow up
|
Bladder Cancer knowledge Scale The intervention is designed to enhance treatment decision making. |
3 month follow up
|
|
Decisional Regret Scale
Časové okno: 6 month follow up
|
Bladder Cancer knowledge Scale The intervention is designed to enhance treatment decision making. |
6 month follow up
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
quality of life
Časové okno: Baseline
|
FACT-BL, Emotional, physical, function, and social Wellbeing Subscales
|
Baseline
|
|
quality of life
Časové okno: 1 month follow up
|
FACT-BL, Emotional, physical, function, and social Wellbeing Subscales
|
1 month follow up
|
|
quality of life
Časové okno: 3 month follow up
|
FACT-BL, Emotional, physical, function, and social Wellbeing Subscales
|
3 month follow up
|
|
quality of life
Časové okno: 6 month follow up
|
FACT-BL, Emotional, physical, function, and social Wellbeing Subscales
|
6 month follow up
|
|
post-surgical self-care
Časové okno: Baseline
|
FACT-BL Ca additional concern
|
Baseline
|
|
post-surgical self-care
Časové okno: 1 month follow up
|
FACT-BL Ca additional concern
|
1 month follow up
|
|
post-surgical self-care
Časové okno: 3 month follow up
|
FACT-BL Ca additional concern
|
3 month follow up
|
|
post-surgical self-care
Časové okno: 6 month follow up
|
FACT-BL Ca additional concern
|
6 month follow up
|
|
CES-D scale Illness Perception Questionnaire (IPQ)
Časové okno: Baseline
|
Baseline
|
|
|
CES-D scale Illness Perception Questionnaire (IPQ)
Časové okno: 1 month follow up
|
1 month follow up
|
|
|
CES-D scale Illness Perception Questionnaire (IPQ)
Časové okno: 3 month follow up
|
3 month follow up
|
|
|
CES-D scale Illness Perception Questionnaire (IPQ)
Časové okno: 6 month follow up
|
6 month follow up
|
|
|
Cancer worries scale
Časové okno: Baseline
|
Baseline
|
|
|
Cancer worries scale
Časové okno: 1 month follow up
|
1 month follow up
|
|
|
Cancer worries scale
Časové okno: 3 month follow up
|
3 month follow up
|
|
|
Cancer worries scale
Časové okno: 6 month follow up
|
6 month follow up
|
Spolupracovníci a vyšetřovatelé
Vyšetřovatelé
- Vrchní vyšetřovatel: Nihal E Mohamed, PhD, Icahn School of Medicine at Mount Sinai
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhad)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
Další identifikační čísla studie
- GCO 09-0479
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Education Intervention
-
Daisy LeZatím nenabírámeRakovina děložního hrdla | Screening rakoviny děložního čípku | HPV
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI); 3-C Institute for Social...Aktivní, ne nábor
-
Tulane UniversityUniversity of Alabama at Birmingham; Louisiana State University Health Sciences... a další spolupracovníciUkončenoCOVID-19 | Systémový lupus erythematodesSpojené státy
-
US Department of Veterans AffairsIndiana University School of MedicineDokončeno
-
Saglik Bilimleri UniversitesiDokončenoLidský papilomavirus (HPV)Krocan
-
Aydin Adnan Menderes UniversityNáborTěhotenství | Vzdělání | Narození | Spokojenost s porodem | Porodní paměťKrocan
-
Saglik Bilimleri UniversitesiDokončenoVzdělávání ošetřovatelství | Zdraví žen | Klimatická změna | Udržitelný rozvojTurecko (Türkiye)
-
National Taiwan University HospitalZatím nenabírámeUltrazvuk v místě péče | Přednemocniční záchranná služba
-
University of South FloridaNational Cancer Institute (NCI)StaženoDětská rakovinaSpojené státy
-
Koç UniversityNáborÚzkost změny klimatu | Povědomí o změně klimatuTurecko (Türkiye)